Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Gross Profit (2016 - 2026)

Myriad Genetics has reported Gross Profit over the past 17 years, most recently at $146.8 million for Q4 2025.

  • Quarterly Gross Profit fell 2.72% to $146.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $576.6 million through Dec 2025, down 1.5% year-over-year, with the annual reading at $576.6 million for FY2025, 1.5% down from the prior year.
  • Gross Profit was $146.8 million for Q4 2025 at Myriad Genetics, up from $143.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $183.7 million in Q2 2021 and troughed at $59.1 million in Q4 2022.
  • The 5-year median for Gross Profit is $136.3 million (2023), against an average of $136.1 million.
  • Year-over-year, Gross Profit crashed 63.25% in 2022 and then surged 128.43% in 2023.
  • A 5-year view of Gross Profit shows it stood at $160.8 million in 2021, then crashed by 63.25% to $59.1 million in 2022, then surged by 128.43% to $135.0 million in 2023, then increased by 11.78% to $150.9 million in 2024, then decreased by 2.72% to $146.8 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Gross Profit are $146.8 million (Q4 2025), $143.8 million (Q3 2025), and $151.8 million (Q2 2025).